Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Stage II Malignant Mesothelioma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT02194231
What this trial is testing

ATREUS - Phase II Study on the Activity of Trabectedin in Patients With Malignant Pleural Mesothelioma (MPM)

Who this might be right for
Malignant Pleural Mesothelioma
Mario Negri Institute for Pharmacological Research 145
Testing effectiveness (Phase 2)Ended earlyNCT02408016
What this trial is testing

Genetically Modified T Cells in Treating Patients With Stage III-IV Non-small Cell Lung Cancer or Mesothelioma

Who this might be right for
Advanced Pleural Malignant MesotheliomaHLA-A*0201 Positive Cells PresentRecurrent Non-Small Cell Lung Carcinoma+8 more
Fred Hutchinson Cancer Center 11
Testing effectiveness (Phase 2)Study completedNCT00030745
What this trial is testing

Combination Chemotherapy Before Surgery in Treating Patients With Mesothelioma of the Lung

Who this might be right for
Malignant Mesothelioma
Swiss Cancer Institute 61
Testing effectiveness (Phase 2)Study completedNCT00309946
What this trial is testing

Cediranib Maleate in Treating Patients With Malignant Mesothelioma That Cannot Be Removed By Surgery

Who this might be right for
Advanced Malignant MesotheliomaEpithelial MesotheliomaLocalized Malignant Mesothelioma+2 more
National Cancer Institute (NCI) 51
Testing effectiveness (Phase 2)Active Not RecruitingNCT06155279
What this trial is testing

Induction Chemo+Immunotherapy in Resectable Epithelioid and Biphasic Pleural Mesothelioma (CHIMERA Study)

Who this might be right for
Pleural Mesothelioma
Istituto Oncologico Veneto IRCCS 41
Testing effectiveness (Phase 2)Study completedNCT05449366
What this trial is testing

Intraperitoneal Paclitaxel for Patients With Primary Malignant Peritoneal Mesothelioma

Who this might be right for
Peritoneal Malignant Mesothelioma
Erasmus Medical Center 7
Testing effectiveness (Phase 2)Study completedNCT02899195
What this trial is testing

Phase II MEDI4736 in Combination With Chemotherapy for First-Line Treatment of Unresectable Mesothelioma

Who this might be right for
MesotheliomaPleural Mesothelioma
PrECOG, LLC. 55
Testing effectiveness (Phase 2)UnknownNCT01869023
What this trial is testing

Phase II Study of Six Hours Low Dose Gemcitabine Plus Cisplatin in the Treatment for Advanced Pleural Mesothelioma

Who this might be right for
Advanced Malignant Pleural Mesothelioma
Instituto Nacional de Cancerologia de Mexico 26
Testing effectiveness (Phase 2)Study completedNCT05918107
What this trial is testing

PM8002 Injection in Combination With Standard Chemotherapy as First Line Therapy in MPM

Who this might be right for
MPM
Biotheus Inc. 31
Not applicableLooking for participantsNCT06910449
What this trial is testing

Hemithoracic Arc Radiotherapy Post Pleural Decortication

Who this might be right for
Malignant Pleural Mesothelioma
Cairo University 45
Not applicableStudy completedNCT00372840
What this trial is testing

Printed Education Materials in Patients Who Are Finishing Treatment for Stage I, Stage II, or Stage IIIA Breast Cancer, Colorectal Cancer, Prostate Cancer, or Chest Cancer

Who this might be right for
Breast CancerColorectal CancerLung Cancer+4 more
Fox Chase Cancer Center 340
Testing effectiveness (Phase 2)Study completedNCT01590160
What this trial is testing

Ganetespib With Platinum, in Patients With Malignant Pleural Mesothelioma

Who this might be right for
Lung Cancer - Malignant Pleural Mesothelioma
University College, London 27
Testing effectiveness (Phase 2)Ended earlyNCT00597116
What this trial is testing

An Efficacy and Safety Study With Vandetanib to Treat Inoperable or Relapsed Malignant Mesothelioma

Who this might be right for
Mesothelioma
Genzyme, a Sanofi Company 25
Testing effectiveness (Phase 2)Study completedNCT00459862
What this trial is testing

Pazopanib in Treating Patients With Malignant Pleural Mesothelioma

Who this might be right for
Advanced Malignant MesotheliomaLocalized Malignant MesotheliomaRecurrent Malignant Mesothelioma
National Cancer Institute (NCI) 34
Testing effectiveness (Phase 2)Study completedNCT03560973
What this trial is testing

A Double Blind, Placebo Controlled, Randomized Phase II Study Evaluating Gemcitabine With or Without Ramucirumab , for II Line Treatment MPM

Who this might be right for
Mesothelioma
Gruppo Oncologico Italiano di Ricerca Clinica 164
Testing effectiveness (Phase 2)Ended earlyNCT02863055
What this trial is testing

Nintedanib as Switch Maintenance Treatment of Pleural Malignant Mesothelioma

Who this might be right for
Malignant Pleural Mesothelioma
European Organisation for Research and Treatment of Cancer - EORTC 37
Testing effectiveness (Phase 2)Ended earlyNCT03644550
What this trial is testing

Anti-Mesothelin Immunotoxin LMB-100 Followed by Pembrolizumab in Malignant Mesothelioma

Who this might be right for
Mesothelioma
National Cancer Institute (NCI) 18
Testing effectiveness (Phase 2)Study completedNCT00002475
What this trial is testing

Cyclophosphamide Plus Vaccine Therapy in Treating Patients With Advanced Cancer

Who this might be right for
Breast CancerColorectal CancerKidney Cancer+3 more
St. Vincent Medical Center - Los Angeles 40
Testing effectiveness (Phase 2)WithdrawnNCT05582031
What this trial is testing

Regorafenib With Tislelizumab in Patients With Selected Mismatch Repair-Proficient/Microsatellite Stable Cancers

Who this might be right for
Anal Squamous Cell CarcinomaColorectal NeoplasmsSoft Tissue Sarcoma+5 more
Translational Research in Oncology
Testing effectiveness (Phase 2)Study completedNCT02303899
What this trial is testing

Combination of Gemcitabine and Imatinib Mesylate in Pemetrexed-pretreated Patients With Pleural Mesothelioma

Who this might be right for
Mesothelioma, Malignant
Istituto Clinico Humanitas 22
Next Page